申请人:Angibaud Patrick René
公开号:US20100222348A1
公开(公告)日:2010-09-02
Compounds of formula (I):
wherein R
1
, R
2
, R
3
, R
4
, R
5
, Z and n have defined meanings, the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary ammonium salts and the stereochemically isomeric forms thereof, and their use for the treatment of PARP-mediated disorders.